Acquired Immunodeficiency Syndrome (AIDS) is characterized by reduced numbers and functional impairment of T lymphocytes. The major emphasis of this investigation will be an examination of the in vitro expandability of peripheral blood lymphocytes from patients with AIDS using protocols designed to examine specific molecular events (e.g. phospholipid and calcium metabolism and kinase activation). These events, which are crucial to Tcell proliferation and functional development, will be investigated using probes of the cell surface (e.g. phospholipase C) and cytosol (e.g. calcium ionophores and protein kinase C modulators). The populations studied will include individuals with AIDS, healthy individuals who are HIV antibody positive, and healthy controls. The lymphocytes from these subjects will be characterized for functionally important structures (e.g. T4, T8, T3, IL-2 receptor) before and after the T-cell expandability studies. The various T cell populations will also be assessed for in vitro cytotoxic function against Epstein Barr Virus transformed autologous B cells. Analysis of retrovirus integration and replication and the use of specific viral inhibitors will concomitantly assess the effect of such agents on Tcell proliferation and HIV replication. The in vitro addition of selected opioids (agonists and antagonists) and cannabinoid compounds will be used to further examine the impact of drugs of abuse in this paradigm. The design and analysis of these protocols will be accomplished via the use of response surface methodology (RSM). The use of RSM will allow for developing optimum expandability protocols and the mechanistic exploration of those factors (e.g. HIV, drugs of abuse) which impact on AIDS related Tcell functionality. The understanding of those factors which result in Tcell dysfunction and the ability to reverse these deficits in vitro could result in the eventual development of adoptive immunotherapy procedures for the treatment of AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004502-03
Application #
3210207
Study Section
(SRCD)
Project Start
1987-07-01
Project End
1990-12-31
Budget Start
1989-07-01
Budget End
1990-12-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
McVicar, D W; McCrady, C W; Merchant, R E (1992) Corticosteroids inhibit the delivery of short-term activational pulses of phorbol ester and calcium ionophore to human peripheral T cells. Cell Immunol 140:145-57
Hoover, S K; Frank, J L; McCrady, C et al. (1991) Activation and in vitro expansion of tumor-reactive T lymphocytes from lymph nodes draining human primary breast cancers. J Surg Oncol 46:117-24
McCrady, C W; Staniswalis, J; Pettit, G R et al. (1991) Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF. Br J Haematol 77:5-15
McVicar, D W; Li, F; McCrady, C W et al. (1991) A comparison of serum-free media for the support of in vitro mitogen-induced blastogenic expansion of cytolytic lymphocytes. Cytotechnology 6:105-13
Massey, G V; McCrady, C W; Dunn, N L et al. (1989) Induction of tumoricidal activity and alterations of growth by interleukin-2 and manipulation of protein kinase C and cytosolic calcium in childhood acute lymphocytic leukemia cells. Leukemia 3:602-10
McCrady, C W; Li, F; Grant, A J et al. (1988) Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+. Cancer Res 48:635-40
McCrady, C W; Ely, C M; Westin, E et al. (1988) Coordination and reversibility of signals for proliferative activation and interleukin-2 mRNA production in resting human T lymphocytes by phorbol ester and calcium ionophore. J Biol Chem 263:18537-44